AMBONI, Marianna
 Distribuzione geografica
Continente #
AS - Asia 11.103
NA - Nord America 5.542
EU - Europa 2.208
SA - Sud America 640
OC - Oceania 56
AF - Africa 45
Continente sconosciuto - Info sul continente non disponibili 5
Totale 19.599
Nazione #
HK - Hong Kong 9.000
US - Stati Uniti d'America 5.440
SG - Singapore 760
CN - Cina 591
BR - Brasile 533
IT - Italia 400
RU - Federazione Russa 395
UA - Ucraina 341
DE - Germania 293
VN - Vietnam 261
IE - Irlanda 217
TR - Turchia 182
SE - Svezia 150
KR - Corea 145
EE - Estonia 107
GB - Regno Unito 99
FI - Finlandia 73
CA - Canada 54
IN - India 41
AR - Argentina 40
FR - Francia 32
AU - Australia 30
BD - Bangladesh 28
NZ - Nuova Zelanda 24
EC - Ecuador 23
JP - Giappone 23
MX - Messico 22
CZ - Repubblica Ceca 16
PL - Polonia 16
NL - Olanda 15
ZA - Sudafrica 15
ID - Indonesia 14
VE - Venezuela 11
AT - Austria 10
PY - Paraguay 10
ES - Italia 9
CO - Colombia 8
IQ - Iraq 8
PK - Pakistan 8
BE - Belgio 7
IL - Israele 7
UZ - Uzbekistan 7
AE - Emirati Arabi Uniti 6
KE - Kenya 6
CL - Cile 5
EU - Europa 5
JM - Giamaica 5
PE - Perù 5
AL - Albania 4
DO - Repubblica Dominicana 4
EG - Egitto 4
ET - Etiopia 4
MA - Marocco 4
NP - Nepal 4
BA - Bosnia-Erzegovina 3
CH - Svizzera 3
GT - Guatemala 3
HR - Croazia 3
ME - Montenegro 3
OM - Oman 3
TN - Tunisia 3
BG - Bulgaria 2
BH - Bahrain 2
BO - Bolivia 2
BS - Bahamas 2
BW - Botswana 2
DZ - Algeria 2
IR - Iran 2
LT - Lituania 2
NI - Nicaragua 2
PA - Panama 2
PR - Porto Rico 2
RS - Serbia 2
SA - Arabia Saudita 2
TH - Thailandia 2
TJ - Tagikistan 2
UY - Uruguay 2
AZ - Azerbaigian 1
CI - Costa d'Avorio 1
CY - Cipro 1
DK - Danimarca 1
DM - Dominica 1
GA - Gabon 1
GF - Guiana Francese 1
GP - Guadalupe 1
HN - Honduras 1
JO - Giordania 1
KY - Cayman, isole 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
LY - Libia 1
MD - Moldavia 1
MN - Mongolia 1
MR - Mauritania 1
NC - Nuova Caledonia 1
RO - Romania 1
RW - Ruanda 1
SI - Slovenia 1
SV - El Salvador 1
Totale 19.597
Città #
Hong Kong 8.988
Ann Arbor 1.105
Princeton 518
Chandler 509
Wilmington 468
Jacksonville 429
Dallas 401
Singapore 307
Houston 248
Ashburn 227
Dublin 204
Woodbridge 201
Izmir 166
Dong Ket 136
Beijing 123
Nanjing 112
Moscow 110
Tallinn 107
Andover 104
Boardman 86
Salerno 69
Munich 65
Pellezzano 64
Düsseldorf 55
Norwalk 53
Ho Chi Minh City 46
Dearborn 44
Shenyang 43
São Paulo 43
Los Angeles 41
Nanchang 39
Naples 36
Fairfield 34
Mestre 34
Hanoi 30
Hebei 29
Redwood City 26
Jiaxing 25
San Francisco 24
Rio de Janeiro 21
The Dalles 20
Changsha 19
New York 18
Pune 18
Rome 18
Tianjin 18
Milan 16
Nuremberg 16
San Diego 16
Washington 16
Council Bluffs 15
Casoria 14
Montreal 14
Santa Clara 13
Turku 13
Belo Horizonte 12
Brooklyn 12
Guarulhos 12
Seoul 12
Auckland 11
Boston 11
Brasília 11
Chennai 11
Guangzhou 11
Sydney 11
Columbus 10
London 10
Warsaw 10
West Jordan 10
Amsterdam 9
Ankara 9
Atlanta 9
Quito 9
Campinas 8
Dhaka 8
Guayaquil 8
Haiphong 8
Stockholm 8
Tokyo 8
Cambridge 7
Cape Town 7
Carapicuíba 7
Curitiba 7
Jinan 7
Osasco 7
Porto Alegre 7
Ribeirão Preto 7
Salvador 7
Santa Maria A Vico 7
Seattle 7
Wuhan 7
Brussels 6
Chicago 6
Dormagen 6
Fortaleza 6
Fuzhou 6
Hefei 6
Nairobi 6
Napoli 6
Tashkent 6
Totale 15.990
Nome #
Step length predicts executive dysfunction in Parkinson’s disease: a 3-year prospective study 959
Sex Differences in Parkinson’s Disease: From Bench to Bedside 621
Quantitative gait assessment in Parkinsonian patients with or without Mild Cognitive Impairment 579
Prevalence and associated features of self-reported freezing of gait in Parkinson disease: The DEEP FOG study 572
Insulin-like growth factor-1 predicts cognitive functions at 2-year follow-up in early, drug-naïve Parkinson's disease. 514
Gender differences in microRNA expression in levodopa-naive PD patients 510
Gait Analysis in Progressive Supranuclear Palsy Phenotypes. 476
Combined regional T1w/T2w ratio and voxel-based morphometry in multiple system atrophy: A follow-up study 473
Treatment of nocturnal disturbances and excessive daytime sleepiness in Parkinson's disease. 410
Default-mode network connectivity in cognitively unimpaired patients with Parkinson disease 408
Fist-Palm Test May Identify Mild Cognitive Impairment and Freezing of Gait in Parkinson's Disease: A Machine Learning Approach 359
The most effective way to obtain long-term memory is to increase first presentation duration of single words 333
Resting-state brain connectivity in patients with Parkinson's disease and freezing of gait. 303
A longitudinal study of cognitive dysfunction in patients affected by Parkinson’s disease with and without freezing of gait 276
Effect of Global Postural Rehabilitation program on spatiotemporal gait parameters of parkinsonian patients: a three-dimensional motion analysis study. 257
Relationship Between Orthostatic Hypotension and Cognitive Functions in Multiple System Atrophy: A Longitudinal Study 255
Dual-task-related gait patterns as possible marker of precocious and subclinical cognitive alterations in Parkinson disease 244
Anxiety is associated with striatal dopamine transporter availability in newly diagnosed untreated Parkinson's disease patients. 234
Classifying Different Stages of Parkinson’s Disease Through Random Forests 232
Metabolomics in Parkinson's disease 217
Diagnostics and Ecological Validity of the Italian Version of the Parkinson's Disease Cognitive Rating Scale 210
Intraocular pressure and choroidal thickness postural changes in multiple system atrophy and Parkinson's disease 197
Validation of an Italian version of the 40-item University of Pennsylvania Smell Identification Test that is physician administered: our experience on one hundred and thirty-eight healthy subjects 190
Lower serum uric acid is associated with mild cognitive impairment in early Parkinson's disease: a 4-year follow-up study 178
Imaging of dopaminergic dysfunction with [123I]FP-CIT SPECT in early-onset parkindisease 171
Apathy and striatal dopamine transporter levels in de-novo, untreated Parkinson's disease patients 171
Validation of the Italian version of carers’ quality-of-life questionnaire for parkinsonism (PQoL Carer) in progressive supranuclear palsy 171
Olfaction in Homozygous and Heterozygous SYNJ1 Arg258Gln Mutation Carriers 157
Anxiety in early Parkinson's disease: Validation of the Italian observer-rated version of the Parkinson Anxiety Scale (OR-PAS) 152
A neuropsychological longitudinal study in Parkinson's patients with and without hallucinations. 151
Measurements of Postural Sway to Classify Freezing of Gait in Parkinson's Disease 144
Apathy in untreated, de novo patients with Parkinson’s disease: validation study of Apathy Evaluation Scale 141
Machine learning can detect the presence of Mild cognitive impairment in patients affected by Parkinson’s Disease 138
Default-mode network connectivity in cognitively unimpaired patients with Parkinson disease 136
Cognitive performances and DAT imaging in early Parkinson's disease with mild cognitive impairment: a preliminary study 133
A longitudinal study on the effects of COVID-19 pandemic on non-motor symptoms in Parkinson's disease 127
Increased bilirubin levels in de novo Parkinson's disease 123
Mild Cognitive Impairment in newly diagnosed Parkinson's disease: A longitudinal prospective study 123
A quantitative analysis of muscular co-activation on EMG signals in spastic patients treated with Botulinum toxin 121
A two-year follow-up study of executive dysfunctions in parkinsonian patients with freezing of gait at on-state. 117
Nonmotor predictors for levodopa requirement in de novo patients with Parkinson's disease 117
A Four-Year Longitudinal Study on Restless Legs Syndrome in Parkinson Disease 116
Serum uric acid is associated with apathy in early, drug-naïve Parkinson’s disease 114
Link between non-motor symptoms and cognitive dysfunctions in de novo, drug-naive PD patients. 113
Clinical and neurological abnormalities in adult celiac disease. 112
Pisa syndrome in Parkinson's disease and parkinsonism: clinical features, pathophysiology, and treatment 110
Quitting smoking: An early non-motor feature of Parkinson's disease? 109
An easy tool to improve accuracy in pre-diagnostic Parkinson's disease population 109
Is serum uric acid related to non-motor symptoms in de-novo Parkinson's disease patients? 108
Resting-state functional connectivity associated with mild cognitive impairment in Parkinson’s disease 108
Freezing of gait and executive functions in patients with Parkinson’s disease 108
Abnormal eating behaviors in progressive supranuclear palsy. 102
Gender and non motor fluctuations in Parkinson's disease: A prospective study 100
Caffeine consumption and the 4-year progression of de novo Parkinson's disease 100
Machine learning can predict mild cognitive impairment in Parkinson's disease 98
Association between dopaminergic dysfunction and anxiety in de novo Parkinson's disease 98
Dopamine transporter availability in motor subtypes of de novo drug-naïve Parkinson’s disease 97
The heterogeneity of early Parkinson's disease: a cluster analysis on newly diagnosed untreated patients. 95
Assessment of apathy minimising the effect of motor dysfunctions in Parkinson’s disease: a validation study of the dimensional apathy scale 94
Biomechanics Parameters of Gait Analysis to Characterize Parkinson's Disease: A Scoping Review 93
Bisphenol A glucuronidation in patients with Parkinson's disease 93
Short-latency afferent inhibition in patients with Parkinson’s disease and freezing of gait 92
Classifying patients affected by Parkinson’s disease into freezers or non-freezers through machine learning 91
The use of University of Pennsylvania Smell Identification Test in the diagnosis of Parkinson's disease in Italy. 90
Regional Gray Matter Atrophy in Patients with Parkinson Disease and Freezing of Gait. 88
The non-motor side of the honeymoon period of Parkinson's disease and its relationship with quality of life: A 4-year longitudinal study 87
Gait patterns in Parkinsonian patients with or without mild cognitive impairment. 86
Segmental progression of cardinal motor symptoms in Parkinson's disease: A pilot study suggesting a practical approach to rate disease course in the early stages. 86
Clinical clusters and dopaminergic dysfunction in de-novo Parkinson disease 86
Presence and progression of non-motor symptoms in relation to uric acid inde novoParkinson's disease 85
Relationship between apathy and cognitive dysfunctions in de novo untreated Parkinson's disease: a prospective longitudinal study. 85
Cerebellar and pyramidal dysfunctions, palpebral ptosis and weakness aspresenting symptoms of PARK-2 84
Resting-state brain networks in patients with Parkinson's disease and impulse control disorders 84
Uric acid relates to dopamine transporter availability in Parkinson's disease. 83
Music Therapy for Motor and Nonmotor Symptoms of Parkinson's Disease: A Prospective, Randomized, Controlled, Single-Blinded Study 83
Serum epidermal growth factor predicts cognitive functions in early, drug-naive Parkinson's disease patients 81
“Response to Apomorphine in early Parkinson’s disease”. 81
Parkinson’s disease and the spectrum of Lewy body disease 81
Insulin-like growth factor-1 and progression of motor symptoms in early, drug-naïve Parkinson's disease. 79
Comment on Szewczyk-Krolikowski et al.: The influence of age and gender on motor and non-motor features of early Parkinson's disease: Initial findings from the Oxford Parkinson Disease Center (OPDC) discovery cohort 79
A metabolomic signature of treated and drug-naïve patients with Parkinson’s disease: a pilot study 79
Multiple system atrophy is associated with changes in peripheral insulin-like growth factor system 78
Mutation in theSYNJ1Gene Associated with Autosomal Recessive, Early-Onset Parkinsonism 77
Gender differences in non-motor symptoms in early, drug naïve Parkinson's disease 76
Apathy in Parkinson's disease: differences between caregiver's report and self-evaluation 75
The Role of Deep Learning and Gait Analysis in Parkinson’s Disease: A Systematic Review 73
Ropinirole as a treatment of restless legs syndrome in patients on chronichemodialysis: an open randomized crossover trial versus levodopa sustainedrelease 73
Resting brain networks in patients with Parkinson's disease and freezing of gait 73
Cognitive contributions to gait and falls: Evidence and implications 72
Do Subjective Memory Complaints Herald the Onset of Mild Cognitive Impairment in Parkinson Disease? 72
Identification by [99mTc]ECD SPECT of anterior cingulate hypoperfusion in progressive supranuclear palsy, in comparison with Parkinson's disease 71
Gender differences in non-motor symptoms in early Parkinson's disease: A 2-years follow-up study on previously untreated patients. 71
Vestibular impairment and adaptive postural imbalance in parkinsonian patients with lateral trunk flexion 71
Cognitive correlates of “pure apathy” in Parkinson's disease 71
Caratteristiche Cliniche 71
Neuropsychological correlates of theory of mind in patients withearly Parkinson's disease. 70
Gait patterns and cognition in Parkinson's disease 70
Comparing PIGD and Akinetic-Rigid subtyping of Parkinson Disease and their stability over time 70
Non-motor symptoms in early Parkinson's disease: a 2-year follow-up study on previously untreated patients. 69
The "eye of the tiger" sign in pure akinesia with gait freezing. 68
Totale 16.538
Categoria #
all - tutte 59.994
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 59.994


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021602 0 0 0 0 107 60 83 6 68 3 95 180
2021/2022829 9 2 12 14 6 1 7 33 112 117 120 396
2022/20231.274 154 67 37 114 203 295 11 111 185 12 61 24
2023/2024772 44 105 40 42 29 90 25 63 35 57 108 134
2024/20252.220 78 20 31 180 80 182 273 203 320 263 296 294
2025/202610.333 1.587 4.538 3.992 216 0 0 0 0 0 0 0 0
Totale 19.994